When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Pulmonary embolism

最后审阅: 16 Aug 2025
最后更新: 05 Jun 2025

小结

定义

病史和体格检查

关键诊断因素

  • chest pain
  • dyspnea
  • tachypnea
  • presyncope or syncope
  • hypotension (systolic BP <90 mmHg)
完整详情

其他诊断因素

  • feeling of apprehension
  • cough
  • tachycardia
  • fever
  • unilateral swelling/tenderness of calf
  • hemoptysis
  • elevated jugular venous pressure
  • sternal heave
  • accentuated pulmonary component of S2
完整详情

危险因素

  • diagnosis of deep vein thrombosis (DVT)
  • major surgery within the preceding 3 months
  • medical hospitalization within the preceding 2 months
  • active cancer
  • previous venous thromboembolic event
  • recent trauma or fracture
  • increasing age
  • pregnancy and postpartum
  • varicose veins
  • paralysis of the lower extremities
  • hereditary thrombophilias
  • factor V Leiden mutation
  • prothrombin G20210A mutation
  • protein C and protein S deficiency
  • antithrombin deficiency
  • antiphospholipid antibody syndrome
  • medical comorbidity
  • use of specific drugs
  • obesity (BMI ≥29 kg/m²)
  • cigarette smoking
  • recent long-duration travel
  • family history of venous thromboembolic (VTE)
  • central venous catheterization
完整详情

诊断性检查

首要检查

  • Pulmonary Embolism Rule-Out Criteria (PERC)
  • Wells criteria/Geneva score/YEARS criteria
  • D-dimer test
  • multiple-detector computed tomographic pulmonary angiography (CTPA)
  • ventilation-perfusion (V/Q) scan
  • coagulation studies
  • BUN and creatinine, hepatic function tests
  • CBC
完整详情

需考虑的检查

  • Point-of-care ultrasound (POCUS)
  • chest x-ray
  • magnetic resonance angiography (MRA)
  • pulmonary angiography
  • transthoracic echocardiography (TTE)
  • electrocardiography (ECG)
  • arterial blood gasses (ABG)
  • thrombophilia screen
  • ultrasonography
  • troponin
完整详情

治疗流程

急症处理

high risk (massive) PE or high clinical probability of PE with shock or hypotension (i.e., systolic BP <90 mmHg), no contraindication to anticoagulation or thrombolysis

high risk or intermediate-high risk, contraindication to anticoagulation or thrombolysis

intermediate-high risk PESI/sPESI score, no contraindication to anticoagulation or thrombolysis

intermediate-low risk or low risk PESI/sPESI score, no contraindication to anticoagulation

intermediate-low risk or low risk PESI/sPESI score, contraindication to anticoagulation

持续性治疗

confirmed PE: provoked

confirmed PE: unprovoked

confirmed PE: pregnant

confirmed PE: cancer-associated

confirmed PE: recurrent PE while on anticoagulation

撰稿人

作者

Scott Stevens, MD

Director

Thrombosis Clinic

Intermountain Medical Center

Murray

Professor of Medicine

Department of Medicine

Intermountain Healthcare and University of Utah

Salt Lake City

UT

利益声明

SS declares that he has no competing interests.

Scott C. Woller, MD

Director

Thrombosis Clinic

Intermountain Medical Center

Murray

Professor

Department of Medicine

Intermountain Healthcare and University of Utah

Salt Lake City

UT

利益声明

SCW declares that he is expecting to receive funding of an investigator initiated grant from Janssen Pharmaceuticals to Intermountain Health with no direct compensation to himself for research in the sum of $500,000 in 2024.

Gabriel V. Fontaine, PharmD, MBA, BCPS

Clinical Pharmacy Manager

Critical Care and Emergency Medicine

Advanced Clinical Pharmacist

Neuroscience Critical Care

Intermountain Medical Center

Murray

UT

利益声明

GVF has received consulting fees and honoraria from AstraZeneca, Chiesi, and Anticoagulation Forum.

鸣谢

Dr Scott M. Stevens, Dr Scott C. Woller, and Dr Gabriel V. Fontaine would like to gratefully acknowledge Drs Geno Merli, Luis H. Eraso, Taki Galanis, Geoffrey Ouma, Miguel Angel de Gregorio, Alicia Laborda, and Seth W. Clemens, previous contributors to this topic.

利益声明

GM has received grants or research support from BMS, J&J, Sanofi-Aventis, Portola, and Janssen; he has served as a Scientific Consultant for BMS, J&J, and Sanofi-Aventis. LHE, TG, GO, MAG, AL, and SWC declare that they have no competing interests.

同行评议者

Keith Wille, MD, MSPH

Associate Professor of Medicine

University of Alabama at Birmingham

Birmingham

AL

利益声明

KW declares that he has no competing interests.

John R. Charpie, MD, PhD

Associate Professor of Pediatrics

Medical Director

Pediatric Cardiothoracic Intensive Care Unit

University of Michigan Congenital Heart Center

C.S. Mott Children's Hospital

Ann Arbor

MI

利益声明

JRC declares that he has no competing interests.

Sanjeev Wasson, MD

Advanced Clinical Fellow

Cleveland Clinic Foundation

Cleveland

OH

Declarações

SW declares that he has no competing interests.

David Jimenez, MD, PhD

Respiratory Physician and Associate Professor

Ramón y Cajal Hospital and Alcalá de Henares University

Respiratory Department and Medicine Department

Madrid

Spain

Declarações

DJ has received consulting fees from Boehringer Ingelheim, Bayer, Leo-Pharm, and Rovi, and lecture fees from Sanofi Aventis.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020 Jan 21;41(4):543-603.Texto completo

Stevens SM, Woller SC, Baumann Kreuziger L, et al. Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report. 2021 Dec;160(6):e545-608.Texto completo  Resumo

American College of Radiology. ACR Appropriateness Criteria®: suspected pulmonary embolism. 2022 [internet publication].Texto completo

Bates SM, Rajasekhar A, Middeldorp S, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv. 2018 Nov 27;2(22):3317-59.Texto completo  Resumo

Stevens SM, Woller SC, Baumann Kreuziger L, et al. Antithrombotic therapy for VTE disease: compendium and review of CHEST guidelines 2012-2021. Chest. 2024 Aug;166(2):388-404.Texto completo  Resumo

Lyman GH, Carrier M, Ay C, et al. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv. 2021 Feb 23;5(4):927-74.Texto completo  Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Pulmonary embolism images
  • Diagnósticos diferenciais

    • Angina, unstable
    • Myocardial infarction, non-ST elevation (NSTEMI)
    • Myocardial infarction, ST-elevation (STEMI)
    Mais Diagnósticos diferenciais
  • Diretrizes

    • NCCN clinical practice guidelines in oncology: cancer-associated venous thromboembolic disease
    • ACR appropriateness criteria: imaging for pulmonary embolism, known clot
    Mais Diretrizes
  • Folhetos informativos para os pacientes

    Pulmonary embolism: what is it?

    Deep vein thrombosis

    Mais Folhetos informativos para os pacientes
  • Calculadoras

    Pulmonary Embolism Wells Score

    Revised Geneva Score for Estimation of the Clinical Probability of Pulmonary Embolism in Adults

    Mais Calculadoras
  • Videos

    Tracheal intubation: animated demonstration

    Bag-valve-mask ventilation: animated demonstration

    Mais vídeos
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal